Entasis Therapeutics

Scroll
Investment area
Novo Ventures
Region
Eastern USA
Date of investment
March 2016
Website
http://www.entasistx.com/

Entasis Therapeutics is a spin out from Astra Zeneca. The company is developing novel antibiotics for treatment of severe Gram-negative infections. The focus is on developing new antibiotics to treat infections resistant to current treatments.